Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases

<p>Abstract</p> <p>Background</p> <p>Primary small cell carcinoma (SCC) of the esophagus is a rare and aggressive tumor with poor prognosis. In this study, we report the clinicopathological characteristics of 21 cases of small cell carcinoma of the esophagus treated at...

Full description

Bibliographic Details
Main Authors: Tian Qiu-Hong, Hou Jin-Hui, Zhang Mei-Fang, Yun Jing-Ping, Fu Jia, Liang Xiao-Man, Wu Qiu-Liang, Rong Tie-Hua
Format: Article
Language:English
Published: BMC 2007-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/7/38
id doaj-c3c4e3ab141b4cc58ade0c37b29add32
record_format Article
spelling doaj-c3c4e3ab141b4cc58ade0c37b29add322020-11-25T02:27:43ZengBMCBMC Cancer1471-24072007-03-01713810.1186/1471-2407-7-38Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 casesTian Qiu-HongHou Jin-HuiZhang Mei-FangYun Jing-PingFu JiaLiang Xiao-ManWu Qiu-LiangRong Tie-Hua<p>Abstract</p> <p>Background</p> <p>Primary small cell carcinoma (SCC) of the esophagus is a rare and aggressive tumor with poor prognosis. In this study, we report the clinicopathological characteristics of 21 cases of small cell carcinoma of the esophagus treated at the Cancer Center of Sun Yat-Sen University, with particular focus on the histologic and immunohistochemical findings.</p> <p>Methods</p> <p>Twenty-one patient records were reviewed including presenting symptoms, demographics, disease stage, treatment, and follow-up. Histologic features were observed and immunohistochemical detection of cytokeratin (CK), epithelial membrane antigen (EMA), neuron specific enolase (NSE), synaptophysin (Syn), chromogranin A (CgA), neuronal cell adhesion molecules (CD56), thyroid transcriptional factor-1 (TTF-1) and S100 protein (S100) was performed.</p> <p>Results</p> <p>The median age of patients in the study was 56 years, with a male-to-female ratio of 3.2:1. Histologically, there were 19 "homogenous" SCC esophageal samples and 2 samples comprised of SCC and well-differentiated squamous cell carcinoma. The percentages of SCC samples with positive immunoreactivity were Syn 95.2%, CD56 76.2%, TTF-1 71.4%, NSE 61.9%, CgA 61.9%, CK 57.1%, EMA 61.9%, and S100 19.0%, respectively. The median patient survival time was 18.3 months after diagnosis. The 2-year survival rate was 28.6%.</p> <p>Conclusion</p> <p>Our study suggests that esophageal SCC has similar histology to SCC that arises in the lung compartment, and Chinese patients have a poor prognosis. Higher proportion of positive labeling of Syn, CD56, CgA, NSE, and TTF-1 in esophageal SCC implicate that they are valuably applied in differential diagnosis of the malignancy.</p> http://www.biomedcentral.com/1471-2407/7/38
collection DOAJ
language English
format Article
sources DOAJ
author Tian Qiu-Hong
Hou Jin-Hui
Zhang Mei-Fang
Yun Jing-Ping
Fu Jia
Liang Xiao-Man
Wu Qiu-Liang
Rong Tie-Hua
spellingShingle Tian Qiu-Hong
Hou Jin-Hui
Zhang Mei-Fang
Yun Jing-Ping
Fu Jia
Liang Xiao-Man
Wu Qiu-Liang
Rong Tie-Hua
Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
BMC Cancer
author_facet Tian Qiu-Hong
Hou Jin-Hui
Zhang Mei-Fang
Yun Jing-Ping
Fu Jia
Liang Xiao-Man
Wu Qiu-Liang
Rong Tie-Hua
author_sort Tian Qiu-Hong
title Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
title_short Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
title_full Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
title_fullStr Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
title_full_unstemmed Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
title_sort primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2007-03-01
description <p>Abstract</p> <p>Background</p> <p>Primary small cell carcinoma (SCC) of the esophagus is a rare and aggressive tumor with poor prognosis. In this study, we report the clinicopathological characteristics of 21 cases of small cell carcinoma of the esophagus treated at the Cancer Center of Sun Yat-Sen University, with particular focus on the histologic and immunohistochemical findings.</p> <p>Methods</p> <p>Twenty-one patient records were reviewed including presenting symptoms, demographics, disease stage, treatment, and follow-up. Histologic features were observed and immunohistochemical detection of cytokeratin (CK), epithelial membrane antigen (EMA), neuron specific enolase (NSE), synaptophysin (Syn), chromogranin A (CgA), neuronal cell adhesion molecules (CD56), thyroid transcriptional factor-1 (TTF-1) and S100 protein (S100) was performed.</p> <p>Results</p> <p>The median age of patients in the study was 56 years, with a male-to-female ratio of 3.2:1. Histologically, there were 19 "homogenous" SCC esophageal samples and 2 samples comprised of SCC and well-differentiated squamous cell carcinoma. The percentages of SCC samples with positive immunoreactivity were Syn 95.2%, CD56 76.2%, TTF-1 71.4%, NSE 61.9%, CgA 61.9%, CK 57.1%, EMA 61.9%, and S100 19.0%, respectively. The median patient survival time was 18.3 months after diagnosis. The 2-year survival rate was 28.6%.</p> <p>Conclusion</p> <p>Our study suggests that esophageal SCC has similar histology to SCC that arises in the lung compartment, and Chinese patients have a poor prognosis. Higher proportion of positive labeling of Syn, CD56, CgA, NSE, and TTF-1 in esophageal SCC implicate that they are valuably applied in differential diagnosis of the malignancy.</p>
url http://www.biomedcentral.com/1471-2407/7/38
work_keys_str_mv AT tianqiuhong primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
AT houjinhui primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
AT zhangmeifang primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
AT yunjingping primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
AT fujia primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
AT liangxiaoman primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
AT wuqiuliang primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
AT rongtiehua primarysmallcellcarcinomaoftheesophagusclinicopathologicalandimmunohistochemicalfeaturesof21cases
_version_ 1724841228184322048